Literature DB >> 19896994

The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties.

Judith G Alamares1, Subbiah Elankumaran, Siba K Samal, Ronald M Iorio.   

Abstract

Newcastle disease virus (NDV) is an avian paramyxovirus that exists as hundreds of strains with widely different virulence properties. The NDV V protein exhibits interferon (IFN) antagonistic activity, which contributes to the virulence of the virus. The IFN-antagonistic activities of the V proteins from the avirulent strain La Sota and the moderately virulent strain Beaudette C (BC) were compared in an assay for the rescue of a recombinant NDV expressing the green fluorescent protein (NDV-GFP). Consistent with the virulence properties of the two viruses, the BC V protein exhibits a 4-fold greater ability to rescue replication of NDV-GFP than the La Sota V protein. Four amino acid differences in the C-terminal region of V, as well as the N-terminal region, contribute to the difference in IFN-antagonistic activity between the two V proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896994      PMCID: PMC2791185          DOI: 10.1016/j.virusres.2009.10.020

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  25 in total

1.  Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus.

Authors:  Y Nagai; H D Klenk; R Rott
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

2.  Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme.

Authors:  Arnold I Freeman; Zichria Zakay-Rones; John M Gomori; Eduard Linetsky; Linda Rasooly; Evgeniya Greenbaum; Shira Rozenman-Yair; Amos Panet; Eugene Libson; Charles S Irving; Eithan Galun; Tali Siegal
Journal:  Mol Ther       Date:  2005-10-28       Impact factor: 11.454

3.  Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus.

Authors:  R L Glickman; R J Syddall; R M Iorio; J P Sheehan; M A Bratt
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence.

Authors:  B P Peeters; O S de Leeuw; G Koch; A L Gielkens
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death.

Authors:  Subbiah Elankumaran; Daniel Rockemann; Siba K Samal
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains.

Authors:  T Toyoda; T Sakaguchi; H Hirota; B Gotoh; K Kuma; T Miyata; Y Nagai
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

7.  The Newcastle disease virus V protein binds zinc.

Authors:  M Steward; A C Samson; W Errington; P T Emmerson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.

Authors:  Zhuhui Huang; Sateesh Krishnamurthy; Aruna Panda; Siba K Samal
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus.

Authors:  Judith M Fontana; Bettina Bankamp; William J Bellini; Paul A Rota
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

10.  Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein.

Authors:  Elizabeth A Corey; Ronald M Iorio
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more
  22 in total

1.  Cell-type-specific innate immune response to oncolytic Newcastle disease virus.

Authors:  Moanaro Biswas; Sandeep R P Kumar; Adria Allen; Wang Yong; Ramadevi Nimmanapalli; Siba K Samal; Subbiah Elankumaran
Journal:  Viral Immunol       Date:  2012-07-18       Impact factor: 2.257

Review 2.  Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy.

Authors:  Fang Huang; Chuanjing Dai; Youni Zhang; Yuqi Zhao; Yigang Wang; Guoqing Ru
Journal:  Front Mol Biosci       Date:  2022-07-04

3.  The interferon antagonistic activities of the V proteins of NDV correlated with their virulence.

Authors:  Xinglong Wang; Ruiyi Dang; Zengqi Yang
Journal:  Virus Genes       Date:  2019-01-31       Impact factor: 2.332

4.  Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.

Authors:  Xing Cheng; Weijia Wang; Qi Xu; James Harper; Danielle Carroll; Mark S Galinski; JoAnn Suzich; Hong Jin
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

5.  Fatal encephalitis caused by Newcastle disease virus in a child.

Authors:  Bénédicte Neven; Christophe Rodriguez; Sarah Winter; Emmanuèle Lechapt; Guillaume Gricourt; Melissa N'debi; Nathalie Boddaert; Despina Moshous; Thomas Blauwblomme; Manoelle Kossorotoff; Fanny Fouyssac; Judith Chareyre; Vanessa Demontant; Fabrice Chretien; Paul-Louis Woerther; Jean-Michel Pawlotsky; Stéphane Blanche
Journal:  Acta Neuropathol       Date:  2021-07-25       Impact factor: 17.088

6.  Virulence of Newcastle disease virus: what is known so far?

Authors:  Jos C F M Dortmans; Guus Koch; Peter J M Rottier; Ben P H Peeters
Journal:  Vet Res       Date:  2011-12-23       Impact factor: 3.683

7.  Previous infection with virulent strains of Newcastle disease virus reduces highly pathogenic avian influenza virus replication, disease, and mortality in chickens.

Authors:  Mar Costa-Hurtado; Claudio L Afonso; Patti J Miller; Eric Shepherd; Ra Mi Cha; Diane Smith; Erica Spackman; Darrell R Kapczynski; David L Suarez; David E Swayne; Mary J Pantin-Jackwood
Journal:  Vet Res       Date:  2015-09-23       Impact factor: 3.683

8.  Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling.

Authors:  Xusheng Qiu; Qiang Fu; Chunchun Meng; Shengqing Yu; Yuan Zhan; Luna Dong; Cuiping Song; Yingjie Sun; Lei Tan; Shunlin Hu; Xiaoquan Wang; Xiaowen Liu; Daxin Peng; Xiufan Liu; Chan Ding
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

9.  Engineered recombinant protein products of the avian paramyxovirus type-1 nucleocapsid and phosphoprotein genes for serological diagnosis.

Authors:  Na Zhao; Christian Grund; Martin Beer; Timm C Harder
Journal:  Virol J       Date:  2018-01-11       Impact factor: 4.099

Review 10.  Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene.

Authors:  Jordan Douglas; Alexei J Drummond; Richard L Kingston
Journal:  Virus Evol       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.